Merck & Co., Inc. Accrued Income Taxes, Current
Merck & Co., Inc. (MRK) had Accrued Income Taxes, Current of $4.22 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Income Taxes, Current $4.22B.
- 2026-03-31: Accrued Income Taxes, Current $3.95B.
- 2025-12-31: Accrued Income Taxes, Current $4.73B.
- 2025-09-30: Accrued Income Taxes, Current $4.85B.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.22B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.95B 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $4.73B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $4.85B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $4.16B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $5.18B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $3.91B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $4.33B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $2.78B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $2.40B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $2.65B 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.98B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $1.49B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.87B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.99B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $1.70B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.44B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $1.57B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.22B 10-K · filed 2023-02-24 | |
| 2021-09-30 | $954.00M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $971.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.49B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $1.60B 10-K · filed 2022-02-25 | $1.57B 10-K · filed 2021-02-25 |
| 2020-09-30 | $984.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.27B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.03B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $736.00M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $873.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $634.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $807.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.97B 10-K · filed 2020-02-26 | |
| 2018-09-30 | $759.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $661.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $717.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $708.00M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $396.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.98B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.33B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.24B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $1.21B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.21B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.86B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.56B 10-K · filed 2017-02-28 | |
| 2015-09-30 | $2.12B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.88B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.45B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.24B 10-K · filed 2016-02-26 | $1.61B 10-K · filed 2015-02-27 |
| 2014-09-30 | $2.47B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $192.00M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $595.00M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $251.00M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $1.30B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $409.00M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.07B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.20B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $1.51B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.09B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.19B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $781.00M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $1.46B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.17B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $1.33B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $1.24B 10-K · filed 2012-02-28 | |
| 2010-09-30 | $1.63B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $879.40M 10-Q · filed 2010-08-06 | |
| 2010-03-31 | $723.00M 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $1.17B 10-K · filed 2011-02-28 | $1.29B 10-K · filed 2010-03-01 |
| 2009-09-30 | $232.00M 10-Q · filed 2009-10-29 | |
| 2009-06-30 | $202.00M 10-Q · filed 2009-07-24 | |
| 2008-12-31 | $1.43B 10-K · filed 2010-03-01 | $183.00M 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |